Document ID: chunk:federal_register_of_legislation:F2019L01013:clause:1_18
Version: federal_register_of_legislation:F2019L01013
Segment Type: clause
Provision Reference: sch 1 cl 18
Character Range: 7958–8516

18  Paragraph 16(1)(b)
Repeal the paragraph, substitute:
           (b) in relation to a medicine that is listed under section 26AE of the Act or a complementary medicine that is registered under section 25 of the Acta statement, pictorial representation or design authorised or required by a government or government authority (not including a foreign government or foreign government authority) under paragraphs 42DL(9)(b) and 42DLB(6)(b) of the Act, or prescribed by the Regulations for the purposes of paragraphs 42DL(9)(c) and 42DLB(6)(c) of the Act.